Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge

Neurochemistry International

Volumn 73, Issue 1, 2014, Pages 16-26

  Gaffaney, Jon D ^a   Shetty, Madhur ^a   Felts, Bruce ^a   Pramod, Akula Bala ^a   Foster, James D ^a   Henry, L Keith ^a   Vaughan, Roxanne A ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Amphetamine; Cocaine; Methamphetamine; Molecular modeling; SCAM

Indexed keywords

COCAINE; CYSTEINE; DOPAMINE TRANSPORTER; LEUCINE; PEPTIDE; PROTEINASE; SODIUM CHLORIDE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; ENDOPROTEINASE ASP-N; METALLOPROTEINASE;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUIFEX AEOLICUS; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; IMMUNOBLOTTING; MALE; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; EXTRACELLULAR MATRIX; METABOLISM; PROTEIN CONFORMATION; SPRAGUE DAWLEY RAT;

AQUIFEX AEOLICUS; RATTUS;

ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR MATRIX; MALE; METALLOENDOPEPTIDASES; MODELS, MOLECULAR; PROTEIN CONFORMATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84902517787     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.11.003     Document Type: Article

References (73)

1. P. Akula Bala, B. Sharma, R. Acharya, J.D. Foster, A.H. Newman, R.A. Vaughan, and L.K. Henry Insights into the binding modes of RTI-82, a cocaine-like photoaffinity ligand, to the dopamine transporter using Rosetta Ligand and Induced-Fit Docking 2012 Neuroscience Meeting Planner, Society for Neuroscience New Orleans, LA (Program No. 42.02, Online)
2. S.G. Amara, and M.J. Kuhar Neurotransmitter transporters: recent progress Annu. Rev. Neurosci. 16 1993 73 93
3. J. Andersen, A.S. Kristensen, B. Bang-Andersen, and K. Stromgaard Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters Chem. Commun. (Camb.) 2009 3677 3692
4. J. Andersen, O. Taboureau, K.B. Hansen, L. Olsen, J. Egebjerg, K. Stromgaard, and A.S. Kristensen Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants J. Biol. Chem. 284 2009 10276 10284
5. T. Beuming, J. Kniazeff, M.L. Bergmann, L. Shi, L. Gracia, K. Raniszewska, A.H. Newman, J.A. Javitch, H. Weinstein, U. Gether, and C.J. Loland The binding sites for cocaine and dopamine in the dopamine transporter overlap Nat. Neurosci. 11 2008 780 789
6. S. Broer, and U. Gether The solute carrier 6 family of transporters Br. J. Pharmacol. 167 2012 256 278
7. J.G. Chen, A. Sachpatzidis, and G. Rudnick The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding J. Biol. Chem. 272 1997 28321 28327
8. N. Chen, J.V. Ferrer, J.A. Javitch, and J.B. Justice Jr. Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter J. Biol. Chem. 275 2000 1608 1614
9. N. Chen, J. Rickey, J.L. Berfield, and M.E. Reith Aspartate 345 of the dopamine transporter is critical for conformational changes in substrate translocation and cocaine binding J. Biol. Chem. 279 2004 5508 5519
10. R. Chen, H. Wei, E.R. Hill, L. Chen, L. Jiang, D.D. Han, and H.H. Gu Direct evidence that two cysteines in the dopamine transporter form a disulfide bond Mol. Cell. Biochem. 298 2007 41 48
11. A.K. Dutta, S. Zhang, R. Kolhatkar, and M.E. Reith Dopamine transporter as target for drug development of cocaine dependence medications Eur. J. Pharmacol. 479 2003 93 106
12. J.V. Ferrer, and J.A. Javitch Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter Proc. Natl. Acad. Sci. USA 95 1998 9238 9243
13. J.R. Field, L.K. Henry, and R.D. Blakely Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine J. Biol. Chem. 285 2010 11270 11280
14. L.R. Forrest, and G. Rudnick The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters Physiology 24 2009 377 386
15. J.D. Foster, B. Pananusorn, and R.A. Vaughan Dopamine transporters are phosphorylated on N-terminal serines in rat striatum J. Biol. Chem. 277 2002 25178 25186
16. J.D. Gaffaney, and R.A. Vaughan Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter Mol. Pharmacol. 65 2004 692 701
17. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
18. H. Hastrup, N. Sen, and J.A. Javitch The human dopamine transporter forms a tetramer in the plasma membrane: cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs J. Biol. Chem. 278 2003 45045 45048
19. L.K. Henry, E.M. Adkins, Q. Han, and R.D. Blakely Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I J. Biol. Chem. 278 2003 37052 37063
20. L.K. Henry, and R.D. Blakely Distinctions between dopamine transporter antagonists could be just around the bend Mol. Pharmacol. 73 2008 616 618
21. L.K. Henry, J.R. Field, E.M. Adkins, M.L. Parnas, R.A. Vaughan, M.F. Zou, A.H. Newman, and R.D. Blakely Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants J. Biol. Chem. 281 2006 2012 2023
22. E.R. Hill, X. Huang, C.G. Zhan, F. Ivy Carroll, and H.H. Gu Interaction of tyrosine 151 in norepinephrine transporter with the 2beta group of cocaine analog RTI-113 Neuropharmacology 61 2011 112 120
23. X. Huang, H.H. Gu, and C.G. Zhan Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations J. Phys. Chem. B 113 2009 15057 15066
24. O. Jardetzky Simple allosteric model for membrane pumps Nature 211 1966 969 970
25. S. Kitayama, S. Shimada, H. Xu, L. Markham, D.M. Donovan, and G.R. Uhl Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding Proc. Natl. Acad. Sci. USA 89 1992 7782 7785
26. J. Kniazeff, L. Shi, C.J. Loland, J.A. Javitch, H. Weinstein, and U. Gether An intracellular interaction network regulates conformational transitions in the dopamine transporter J. Biol. Chem. 283 2008 17691 17701
27. H. Koldso, H.E. Autzen, J. Grouleff, and B. Schiott Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations PLoS One 8 2013 e63635
28. H. Krishnamurthy, and E. Gouaux X-ray structures of LeuT in substrate-free outward-open and apo inward-open states Nature 481 2012 469 474
29. A.S. Kristensen, J. Andersen, T.N. Jorgensen, L. Sorensen, J. Eriksen, C.J. Loland, K. Stromgaard, and U. Gether SLC6 neurotransmitter transporters: structure, function, and regulation Pharmacol. Rev. 63 2011 585 640
30. B.K. Krueger Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus J. Neurochem. 55 1990 260 267
31. J.K. Leman, R. Mueller, M. Karakas, N. Woetzel, and J. Meiler Simultaneous prediction of protein secondary structure and transmembrane spans Proteins 81 2013 1127 1140
32. L.B. Li, N. Chen, S. Ramamoorthy, L. Chi, X.N. Cui, L.C. Wang, and M.E. Reith The role of N-glycosylation in function and surface trafficking of the human dopamine transporter J. Biol. Chem. 279 2004 21012 21020
33. S.M. Li, T.A. Kopajtic, M.J. O'Callaghan, G.E. Agoston, J. Cao, A.H. Newman, and J.L. Katz N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects J. Pharmacol. Exp. Ther. 336 2011 575 585
34. Z. Lin, W. Wang, and G.R. Uhl Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains Mol. Pharmacol. 58 2000 1581 1592
35. C.J. Loland, R.I. Desai, M.F. Zou, J. Cao, P. Grundt, K. Gerstbrein, H.H. Sitte, A.H. Newman, J.L. Katz, and U. Gether Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors Mol. Pharmacol. 73 2008 813 823
36. C.J. Loland, C. Granas, J.A. Javitch, and U. Gether Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding J. Biol. Chem. 279 2004 3228 3238
37. S. Mager, C. Min, D.J. Henry, C. Chavkin, B.J. Hoffman, N. Davidson, and H.A. Lester Conducting states of a mammalian serotonin transporter Neuron 12 1994 845 859
38. L.J. McGuffin, K. Bryson, and D.T. Jones The PSIPRED protein structure prediction server Bioinformatics 16 2000 404 405
39. A.K. Meinild, H.H. Sitte, and U. Gether Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter J. Biol. Chem. 279 2004 49671 49679
40. 2+ modulation of neurotransmitter transporters Handb. Exp. Pharmacol. 2006 1 22
41. K. Norgaard-Nielsen, L. Norregaard, H. Hastrup, J.A. Javitch, and U. Gether Zn(2+) site engineering at the oligomeric interface of the dopamine transporter FEBS Lett. 524 2002 87 91
42. L. Norregaard, D. Frederiksen, E.O. Nielsen, and U. Gether Delineation of an endogenous zinc-binding site in the human dopamine transporter EMBO J. 17 1998 4266 4273
43. L. Norregaard, C.J. Loland, and U. Gether Evidence for distinct sodium-, dopamine-, and cocaine-dependent conformational changes in transmembrane segments 7 and 8 of the dopamine transporter J. Biol. Chem. 278 2003 30587 30596
44. M.L. Parnas, J.D. Gaffaney, M.F. Zou, J.R. Lever, A.H. Newman, and R.A. Vaughan Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4- chloro phenyl)tropane implicates proximity of cocaine and substrate active sites Mol. Pharmacol. 73 2008 1141 1150
45. A. Penmatsa, K.H. Wang, and E. Gouaux X-ray structure of dopamine transporter elucidates antidepressant mechanism Nature 503 2013 85 90
46. C.L. Piscitelli, H. Krishnamurthy, and E. Gouaux Neurotransmitter/sodium symporter orthologue LeuT has a single high-affinity substrate site Nature 468 2010 1129 1132
47. P. Plenge, L. Shi, T. Beuming, J. Te, A.H. Newman, H. Weinstein, U. Gether, and C.J. Loland Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter J. Biol. Chem. 287 2012 39316 39326
48. P. Plenge, and O. Wiborg High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions Neurosci. Lett. 383 2005 203 208
49. A.B. Pramod, J. Foster, L. Carvelli, and L.K. Henry SLC6 transporters: structure, function, regulation, disease association and therapeutics Mol. Aspects Med. 34 2013 197 219
50. M. Quick, L. Shi, B. Zehnpfennig, H. Weinstein, and J.A. Javitch Experimental conditions can obscure the second high-affinity site in LeuT Nat. Struct. Mol. Biol. 19 2012 207 211
51. M. Rajabi, E. de Leeuw, M. Pazgier, J. Li, J. Lubkowski, and W. Lu The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability J. Biol. Chem. 283 2008 21509 21518
52. M.E. Reith, J.L. Berfield, L.C. Wang, J.V. Ferrer, and J.A. Javitch The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter J. Biol. Chem. 276 2001 29012 29018
53. M.E. Reith, C. Xu, and L.L. Coffey Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding Biochem. Pharmacol. 52 1996 1435 1446
54. K.C. Schmitt, and M.E. Reith Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse Ann. N.Y. Acad. Sci. 1187 2010 316 340
55. + and substrate is triggered by substrate in a second binding site Mol. Cell 30 2008 667 677
56. S.K. Singh, C.L. Piscitelli, A. Yamashita, and E. Gouaux A competitive inhibitor traps LeuT in an open-to-out conformation Science 322 2008 1655 1661
57. S.K. Singh, A. Yamashita, and E. Gouaux Antidepressant binding site in a bacterial homologue of neurotransmitter transporters Nature 448 2007 952 956
58. C.A. Smith, and T. Kortemme Backrub-like backbone simulation recapitulates natural protein conformational variability and improves mutant side-chain prediction J. Mol. Biol. 380 2008 742 756
59. T. Stockner, T.R. Montgomery, O. Kudlacek, R. Weissensteiner, G.F. Ecker, M. Freissmuth, and H.H. Sitte Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model PLoS Comput. Biol. 9 2013 e1002909
60. D. Sulzer How addictive drugs disrupt presynaptic dopamine neurotransmission Neuron 69 2011 628 649
61. G. Tanda, A.H. Newman, and J.L. Katz Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors Adv. Pharmacol. 57 2009 253 289
62. R.A. Vaughan Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping Mol. Pharmacol. 47 1995 956 964
63. R.A. Vaughan, and J.D. Foster Mechanisms of dopamine transporter regulation in normal and disease states Trends Pharm. Sci. 34 2013 489 496
64. R.A. Vaughan, R.A. Huff, G.R. Uhl, and M.J. Kuhar Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes J. Biol. Chem. 272 1997 15541 15546
65. R.A. Vaughan, and M.J. Kuhar Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis J. Biol. Chem. 271 1996 21672 21680
66. R.A. Vaughan, M.L. Parnas, J.D. Gaffaney, M.J. Lowe, S. Wirtz, A. Pham, B. Reed, S.M. Dutta, K.K. Murray, and J.B. Justice Affinity labeling the dopamine transporter ligand binding site J. Neurosci. Methods 143 2005 33 40
67. H. Wang, J. Elferich, and E. Gouaux Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like context Nat. Struct. Mol. Biol. 19 2012 212 219
68. H. Wang, A. Goehring, K.H. Wang, A. Penmatsa, R. Ressler, and E. Gouaux Structural basis for action by diverse antidepressants on biogenic amine transporters 2013 Nature
69. + and substrates J. Neurosci. Methods 131 2003 27 33
70. B. Wenge, and H. Bonisch The role of cysteines and histidins of the norepinephrine transporter Neurochem. Res. 38 2013 1303 1314
71. C. Xu, L.L. Coffey, and M.E. Reith Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [3H]WIN 35,428 binding Naunyn-Schmiedeberg's Arch. Pharmacol. 355 1997 64 73
72. -dependent neurotransmitter transporters Nature 437 2005 215 223
73. Z. Zhou, J. Zhen, N.K. Karpowich, C.J. Law, M.E. Reith, and D.N. Wang Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures Nat. Struct. Mol. Biol. 16 2009 652 657